Internal Medicine

The FDA recommends additional safety and efficacy data from the ongoing REGENERATE trial.

Heron Therapeutics is expected to meet with the FDA and resubmit an NDA for the post-operative opioid alternative.

The most common type of support needed is psychosocial and instrumental activities of daily living.

Women with premature ovarian insufficiency fare better with combined oral contraceptives compared to low-dose hormone therapy.

Those with ≥150 min per week in moderated or vigorous activities were low risk while those with less than 150 or sedentary activity were higher risk.

Both dosage groups of the study drug achieved at least a 50-meter increase from baseline to week 24 on the six-minute walk distance test.

Data from a simulation performed by investigators from Harvard Medical School is detailing the potential losses in revenue primary care practices are expected to experience in 2020.

Treatment with treprostinil of up to 12 breaths per session four-times per data was well-tolerated, with a safety profile consistent with previous studies.

Survey findings suggest EHRs enhance education for fellows but the time demands of data and order entry can be a negative of the technology.

In an era of triple therapy combinations, what might a tailored approach look like?

New findings from the 8000-plus patient ETHOS trial shows triple inhaler therapy siginificantly betters patient mortality and symptoms over 52 weeks versus dual therapy.

An analysis of the MARINER trial is diving deeper into the impact of post-discharge prophylaxis with rivaroxaban in patients with more severe renal impairment.

Better usability will support better relationships between physicians, their electronic health record systems, and their patients, along with the overall well-being of physicians.

New research suggests the microbiome from the tongue coating of patients with heart failure contains unique differences to those of healthy patients.

The median 12-month risk of clinical relapse in patients with MES 1 was 28.7%, while the estimated annual risk of clinical relapse in patients with a MES 0 was 13.7%.

Ken Ataga, MD, discusses new developments in interpreting the condition's progression and effect on patients.

Currently, there is not an approved test for CTE in living patients.

A trio of clinicians discuss what needs to occur for telemedicine to be seen as a positive in reducing burnout during the ongoing pandemic.

Many tools are becoming available to psychiatrists who need to strengthen their reach of care outside the office.

The COVID-19 pandemic accelerated plans to make changes within their electronic health record system for a trio of Saint Louis University doctors.

A 20-year dream becomes a necessity in the days after COVID-19 began to spike. Who helped to bring it practice, and what does it look like now?

Artificial intelligence has the potential to enhance many aspects of healthcare in the US, including patient and clinical outcomes, while reducing costs.

The surprise surrounding healthcare’s embrace of technology in past months does not consider how willing physicians are to find and use the right tools.

More than 80% of children and parents found the weekly injections preferable to daily injections.

New research suggests signs a person may be more susceptible to type 2 diabetes later in life are visible in children as young as 8 years old.